1. Sakai H, Kurokawa K, Saito T, Shiiki H, Nishi S, Mitarai T, Yokoyama H, Yoshimura A, Yorioka N. Guidelines for the management of refractory nephrotic syndrome—from investigations between 1997 and 2001—research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare. Nihon Jinzo Gakkai Shi. 2002;44:751–61.
2. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 1993;329:85–9.
3. Honkanen E, Tornroht T, Grohagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephoropathy. Nephrol Dial Transplant. 1992;7:S35–41.
4. KDIGO Working Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2012;2:S186–97.
5. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R. A randomized study comparing methylprednisolone plus chlorambucil versus methylpredonisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol. 1998;9:444–50.